This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Cancer Cell International Open Access 29 February 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Leclerc GJ, Mou C, Leclerc GM, Mian AM, Barredo JC . Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy. Leukemia 2010; 24: 552–562.
Einsiedel HG, Kawan L, Eckert C, Witt O, Fichtner I, Henze G et al. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia. Leukemia 2006; 20: 1435–1436.
Webb JL . Effect of More than One Inhibitor. Enzymes and Metabolic Inhibitors, vol. 1. Academic Press: New York, 1963, pp 66–79 and 487–512.
Kano Y, Akutsu M, Tsunoda S, Izumi T, Kobayashi H, Mano H et al. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines. Invest New Drugs 2007; 25: 31–40.
Prasad P, Vasquez H, Das CM, Gopalakrishnan V, Wolff JE . Histone acetylation resulting in resistance to methotrexate in choroid plexus cells. J Neurooncol 2009; 91: 279–286.
Sur P, Fernandes DJ, Kute TE, Capizzi RL . L-asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y. Cancer Res 1987; 47: 1313–1318.
Fernandes DJ, Sur P, Kute TE, Capizzi RL . Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia. Cancer Res 1988; 48: 5638–5644.
Wolfrom C, Hartmann R, Fengler R, Bruhmuller S, Ingwersen A, Henze G . Randomized comparison of 36-h intermediate-dose versus 4-h high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 1993; 11: 827–833.
Acknowledgements
This work was supported by a grant of Berliner Krebsgesellschaft e.v.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bastian, L., Einsiedel, H., Henze, G. et al. The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells. Leukemia 25, 359–361 (2011). https://doi.org/10.1038/leu.2010.259
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.259
This article is cited by
-
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Cancer Cell International (2016)